MetaCap

Certara (CERT) vs PagerDuty (PD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

PagerDuty (PD) has outperformed Certara (CERT) over the past year, losing 1.7% versus a loss of 30.7%. Over five years, PD leads with a -62.8% price change compared with -76.3% for CERT. Certara is the larger company by market cap ($1.37 billion vs $1.21 billion), about 1.1 times the size.

On valuation, PagerDuty trades at a lower forward P/E (10.5x vs 23.0x for Certara).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CERT-30.70%PD-1.73%
+8%-30%-69%
Oct 7, 20251 yearOct 7, 2026
CERT-73.37%PD-61.05%
+33%-30%-92%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CERT versus PD key metrics
MetricCERTPD
Share price$8.96$15.37
Market cap$1.37B$1.21B
1-day change-3.34%-0.45%
YTD return+1.70%+17.24%
1-year return-30.70%-1.73%
5-year return-76.32%-62.80%
P/E ratio (TTM)—7.61
Forward P/E23.0410.47
EPS (TTM)$-0.14$2.02
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$13.12$16.77
52-week low$4.45$5.70
Distance from 52-week high-31.71%-8.35%
Analyst consensusbuynone
Avg. price target upside-3.79%-17.76%
Average volume3.07M1.56M
Shares outstanding152.54M78.65M
Employees1,5151,155
SectorTechnologyTechnology
IndustryComputer Software: Prepackaged SoftwareComputer Software: Prepackaged Software

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • PD has outperformed CERT by 29.0 percentage points over the past year.

About Certara

CERT stock →

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.

Technology · Computer Software: Prepackaged Software · 1,515 employees

About PagerDuty

PD stock →

PagerDuty, Inc. engages in the operation of a digital operations management platform in the United States and internationally.

Technology · Computer Software: Prepackaged Software · 1,155 employees

CERT vs PD FAQ

Which is bigger, Certara or PagerDuty?

Certara (CERT) is larger, with a market capitalization of $1.37B compared with $1.21B for PagerDuty (PD).

Which stock has performed better over the past year, CERT or PD?

PD returned -1.73% over the past 12 months, compared with -30.70% for CERT (price return, excluding dividends). Past performance does not predict future results.

Are Certara and PagerDuty in the same industry?

Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.

More comparisons